Abstract：
:The use of triple regimens, often called highly active antiretroviral therapy (HAART), generally involving 2 nucleoside analogues and an HIV protease inhibitor, have been endorsed as the standard of care for persons with HIV initiating therapy by a number of sets of international guidelines. The widespread availability of protease inhibitor-containing regimens has been associated with a dramatic drop in the incidence of new AIDS events and mortality throughout the developed world. Use of HAART regimens, particularly in treatment-naïve individuals, is also associated with dramatic reductions in HIV RNA load, rises in CD4+ cell numbers and improvements in some aspects of immune function. However, protease inhibitor therapy is associated with a range of adverse effects, which varies between agents, and regimens frequently involve inconvenient administration schedules and disruption to patient's lives. Thus, the undoubted benefits of antiretroviral therapy come at some cost in terms of both physical and psychological morbidity to the recipient. In assessing an individual for therapy, consideration of the risk of disease events and the benefit of therapy in reducing or preventing these events must be weighed against the potential of therapy to cause morbidity. Using these criteria, we suggest that an individual with a 3 year risk of disease progression of less than 10% (based on CD4+ cell count and HIV RNA load) is more likely to a experience a morbidity if treated with HAART than if left untreated and monitored. For individuals with higher risks of HIV progression the risk versus benefit of initiating therapy may, in many cases, still be in favour of no therapy and continued observation. This will vary depending on the individuals risks (such as family and past medical history) and on the choice of agents in the regimen, some regimens having greater risks than others.
journal_name
Drug Safjournal_title
Drug safetyauthors
Moyle GJ,Gazzard BGdoi
10.2165/00002018-199920040-00002keywords:
subject
Has Abstractpub_date
1999-04-01 00:00:00pages
299-321issue
4eissn
0114-5916issn
1179-1942journal_volume
20pub_type
杂志文章,评审相关文献
DRUG SAFETY文献大全abstract：BACKGROUND:Researchers using observational data to understand drug effects must make a number of analytic design choices that suit the characteristics of the data and the subject of the study. Review of the published literature suggests that there is a lack of consistency even when addressing the same research question...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/s40264-013-0103-1
更新日期：2013-10-01 00:00:00
abstract：:The clinician prescribing beta-blockers for his or her patients is faced with an often difficult situation. There are many beta-blockers, each with its own pharmacological profile. Patients are often taking multiple medications, thus increasing the risk of both anticipated and unexpected drug interactions. Reports of ...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-199513060-00005
更新日期：1995-12-01 00:00:00
abstract：:In this narrative review, a brief summary of theoretical approaches to risk perception is followed by an analysis of some of the special factors influencing risk perception and risk communication in sub-Saharan Africa. Examples of recent and emergent local medicines and vaccine controversies in several countries are g...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.1007/BF03261990
更新日期：2012-11-01 00:00:00
abstract：INTRODUCTION:Previously, an app has been developed for healthcare professionals (HCPs) and patients to report adverse drug reactions (ADRs) to national medicines agencies and to receive drug safety information. OBJECTIVE:This study aimed to assess (1) European HCPs' and patients' interest in an app for this two-way ri...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/s40264-018-0648-0
更新日期：2018-07-01 00:00:00
abstract：:The treatment of Lennox-Gastaut syndrome has been improved for some patients by the introduction of adjunctive therapy with newer anticonvulsants such as lamotrigine and topiramate and the availability of vagal nerve stimulation and the re-emergence of the use of the ketogenic diet in recent years. The place of standa...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-200022060-00005
更新日期：2000-06-01 00:00:00
abstract：:Pelargonium (Pelargonium sidoides DC and P. reniforme Curtis) is reported to have immune modulating properties and antibacterial activity, and Pelargonium extracts have been used for the treatment of respiratory tract and gastrointestinal infections. Introduced in the early 1980s in Germany, Umckaloabo (ISO Arzneimitt...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.2165/00002018-200730080-00004
更新日期：2007-01-01 00:00:00
abstract：:Data on the efficacy and tolerability of antiretrovirals in children are limited as, in contrast to adult studies, large paediatric cohort studies are lacking. Thus, data pertaining to adults are often extrapolated to children despite the acknowledgement that children are not little adults. This review summarises info...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-200225140-00001
更新日期：2002-01-01 00:00:00
abstract：:Many drug products contain excipients which perform important functions in terms of stability, solubility and identification. Excipients should not be considered as inactive ingredients, as they have been associated with a wide range of adverse reactions in some individuals. Monitoring for excipient toxicity is import...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-199000051-00015
更新日期：1990-01-01 00:00:00
abstract：:Orally administered levodopa remains the most effective symptomatic treatment for Parkinson's disease. The introduction of levodopa therapy is often delayed, however, because of the fear that it might be toxic for the remaining dopaminergic neurons, and thus accelerate the deterioration of the patient's condition. Evi...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-199921050-00001
更新日期：1999-11-01 00:00:00
abstract：:Communications about the safety and effectiveness of human drugs can influence patients' and prescribers' perceptions and behaviors, which in turn can affect the public's health more broadly. We conducted a critical review of the literature on the unintended effects from communicating information to the public about s...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.1007/s40264-019-00840-3
更新日期：2019-10-01 00:00:00
abstract：:The purpose of this review is to assess the benefits and risks associated with the use of the ketolide antibacterial telithromycin, currently licensed for the treatment of adults with mild to moderate community-acquired pneumonia (CAP). Telithromycin is active against both the major (Streptococcus pneumoniae, Haemophi...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-200831070-00002
更新日期：2008-01-01 00:00:00
abstract：BACKGROUND:The roll out of various public health programmes involving mass administration of medicines calls for the deployment of responsive pharmacovigilance systems to permit identification of signals of rare or even common adverse reactions. In developing countries in Africa, these systems are mostly absent and the...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.2165/00002018-200831100-00005
更新日期：2008-01-01 00:00:00
abstract：:A spectrum of adverse drug reactions that are caused by the combined action of drugs and viruses has been described: ampicillin rash in acute infectious mononucleosis; Reye's syndrome; hypersensitivity reactions to sulphonamides in patients with HIV infection; drug-induced agranulocytosis; paracetamol (acetaminophen) ...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-199716010-00001
更新日期：1997-01-01 00:00:00
abstract：INTRODUCTION:Reframing side-effect information in patient information leaflets (PILs) in terms of those who remain side-effect-free may reduce negative expectations and side-effects, although there are concerns this may impact informed consent. This study compared two versions of positively framed PILs with current pra...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/s40264-020-00959-8
更新日期：2020-10-01 00:00:00
abstract：OBJECTIVES:Difficulty sleeping is a recognised tobacco withdrawal symptom, but sleep problems, like application site reactions, are commonly reported as adverse reactions to transdermal nicotine therapy. However, no studies have examined potential predictive factors associated with the occurrence of expected adverse ex...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.2165/00002018-199920060-00007
更新日期：1999-06-01 00:00:00
abstract：BACKGROUND:In November 2009, a vaccination campaign against Influenza A (H1N1) was started in the Netherlands. The accelerated registration procedure of the vaccines used in this campaign and the use of these vaccines on a large scale indicated a need for real-time safety monitoring. OBJECTIVE:To describe the processi...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.2165/11539270-000000000-00000
更新日期：2010-12-01 00:00:00
abstract：:Intranasal corticosteroids and intranasal antihistamines are efficacious topical therapies in the treatment of allergic rhinitis. This review addresses their relative roles in the management of this disease, focusing on their safety and tolerability profiles. The intranasal route of administration delivers drug direct...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-200326120-00003
更新日期：2003-01-01 00:00:00
abstract：BACKGROUND:Eosinophilic pneumonia (EP) has been noted in association with daptomycin use. The product labelling was recently updated to include EP in the Warnings and Precautions and Post-Marketing Experience sections. OBJECTIVE:The objective of this study was to analyse adverse event (AE) reports submitted to the US ...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/11597460-000000000-00000
更新日期：2012-06-01 00:00:00
abstract：INTRODUCTION:Electronic healthcare databases (EHDs) are used increasingly for post-marketing drug safety surveillance and pharmacoepidemiology in Europe and North America. However, few studies have examined the potential of these data sources in China. METHODS:Three major types of EHDs in China (i.e., a regional commu...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/s40264-017-0589-z
更新日期：2018-01-01 00:00:00
abstract：:The New Zealand Intensive Medicines Monitoring Programme (IMMP) undertakes prospective observational cohort studies on selected new drugs in the early postmarketing period using prescription-event monitoring (PEM) methodology with the purpose of identifying signals of previously unrecognised ADRs and establishing risk...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.2165/00002018-200225060-00007
更新日期：2002-01-01 00:00:00
abstract：:This 'Erice Call for Change' is a report from a group of experts, patients and patient representatives who met in Erice in September 2019 following previous similar meetings after the original Erice Declaration (1996). The aim of the meeting was to discuss the challenge of causal complexity and individual variation in...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/s40264-020-00919-2
更新日期：2020-06-01 00:00:00
abstract：:Older people in the UK receive a disproportionate amount of medication. They comprise 18% of the population but receive 45% of all prescription items. Not surprisingly they experience drug-related illnesses - in 1980, 1 in 10 admissions to acute geriatric units were wholly or partly due to adverse drug reactions. Drug...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-199819040-00001
更新日期：1998-10-01 00:00:00
abstract：:Paraquat is a bipyridyl compound with no known chronic toxicity or teratogenicity. It is poorly absorbed when inhaled, but causes severe illness when ingested orally, death usually occurring within 2 days of ingestion of 50 mg/kg. At lower doses death may be delayed for several weeks. The toxic compound accumulates in...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-199005040-00002
更新日期：1990-07-01 00:00:00
abstract：:Current key challenges and controversies encountered in the identification of potentially hepatotoxic drugs and the assessment of drug-induced liver injury (DILI) are covered in this article. There is substantial debate over the classification of DILI itself, including the definition and validity of terms such as 'int...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/BF03261997
更新日期：2012-12-01 00:00:00
abstract：:Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-200730030-00005
更新日期：2007-01-01 00:00:00
abstract：:In August 2015, the US Food and Drug Administration (FDA) made the controversial decision to approve flibanserin (Addyi®) for women experiencing hypoactive sexual desire disorder. A number of factors contributed to disagreements regarding the FDA's decision, including the product's two prior failed FDA reviews, the un...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/s40264-015-0389-2
更新日期：2016-05-01 00:00:00
abstract：BACKGROUND:At time of approval, knowledge of the full benefit risk of any drug is limited, in particular with regards to safety. Post-approval surveillance of potential drug safety concerns is recognized as an important task of regulatory agencies. For innovative, often first-in-class drugs, safety knowledge at time of...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.1007/s40264-013-0094-y
更新日期：2013-11-01 00:00:00
abstract：:To estimate the frequency of adverse effects associated with the use of the transdermal nicotine patch, we abstracted and analysed data from 47 reports of 35 clinical trials. The meta-analysis presented here represents a synthesis of data from 41 groups of nicotine patch recipients totalling 5501 patients, and 33 grou...
journal_title：Drug safety
pub_type： 杂志文章,meta分析
doi：10.2165/00002018-199818040-00005
更新日期：1998-04-01 00:00:00
abstract：:Betahistine is a structural analogue of histamine that is prescribed for the treatment of vestibular disorders such as Ménière's disease and the symptomatic treatment of vertigo. It is estimated from sales information that >130 million patients have been exposed to the drug since its registration in 1968. In this revi...
journal_title：Drug safety
pub_type： 杂志文章
doi：10.2165/00002018-200629110-00004
更新日期：2006-01-01 00:00:00
abstract：:Zopiclone is a cyclopyrrolone hypnosedative that is chemically unrelated to the benzodiazepines but nevertheless potentiates gamma-aminobutyric acid-mediated neuronal inhibition, and has demonstrated proven efficacy and good tolerability in the treatment of insomnia over 15 years of use. Zopiclone is indicated for sho...
journal_title：Drug safety
pub_type： 杂志文章,评审
doi：10.2165/00002018-199921060-00003
更新日期：1999-12-01 00:00:00
